Planning to invest Rs 10 lakh overseas? Here are the markets to consider and how to do it rightFor global diversification, experts recommend a diversified, disciplined approach across regions.
Actress Samantha Prabhu’s perfume brand Secret Alchemist secures $3 million from Unilever Ventures, othersThe round was a mix of primary and secondary capital. Of the total amount, $2.5 million was primary capital and the remainder was secondary...
ETMarkets Smart Talk: We believe 2023 will be a year of accumulation for equities: Kunal ValiaThe Budget exercise has been positive for both equities and bonds as an asset class. From a macro perspective, the fiscal deficit estimate ...
Sudhir Vaila looks to raise up to Rs 500 croreDeutsche Bank along with another foreign lender may extend the three-year credit expected to come from the lender’s overseas branch, two pe...
Sun to overhaul business practices to allay concernsSun Pharma's domestic formulations biz would be transitioned from Aditya Medisales to a wholly owned arm.
Sun promoters pledged firm's shares for SurakshaShanghvi's brother-in-law and realty co owner Valia denies drugmaker stood guarantee for fundraising.
Sun Pharma promoters take a hit on personal investmentsSome of their biggest personal investments have been in power and real estate, and both sectors and their holdings have taken a beating, ac...
Governance cloud over Sun Pharma, stock at 6-month lowA Sun spokesperson also added that some of the information presented is more than 10-15 years old.
Jaypee Infratech bidder wants JAL to pay fine for delay in flat deliveryThe new owners have proposed to maintain an escrow account for each project where money coming from homebuyers will be deposited.
Dark horse may pip Adani, Kotak to Jaypee InfraSudhir Valia is a relative of Sun Pharma promoter Dilip Sanghvi and a director on the company’s board. The offer by the low-profile busines...
IRDA gives R1 nod to ITI for reinsurance businessThe reinsurance market in India is estimated to be $2billion. ITI Investment is a subsidiary of Fortune Financial Services, which is contro...
Sun Pharmaceuticals honcho Sudhir Valia plans to offer loans to strapped companiesValia, executive director of Sun Pharma and one of the key strategists behind the Mumbai drug maker's meteoric rise, has now set his sights...
Sun Pharma’s Sudhir Valia joins payments bank race; to pick up 51% in Pay Point India NetworkValia confirmed he is investing in Pay Point but said the terms were subject to it getting the licence. He didn’t disclose how much he woul...
Sun Pharma co-promoter gets top gun for financial services businessSudhir Valia, who hit the spotlight for a stake-purchase in mobile service operator Uninor, has roped in a top money manager to build a ful...
Sun Pharma may fund new telecom joint-venture with TelenorIndia's fifth largest pharma company Sun Pharma may indirectly finance its executive director Sudhir Valia's investment in Telewings Commun...
- Sudhir Valia of Sun Pharmaceuticals may buy stake in brokerage company Fortune Financial Services
Valia, who is also one of the co-promoters of Sun, may buy 20% held by Poonja family in Fortune Financial Services.
- Facebook and social media bringing flaws of different brands to highlight
Social media can be as fickle as it is effective. Brands are now realising that social media backlash can be bruising & brutal.